共 31 条
- [31] Randomized phase 2 study of maintenance olaparib vs olaparib plus durvalumab for DNA damage repair (DDR) gene mutated unresectable or metastatic biliary tract cancer (BTC) with durable response to first-line platinum-based chemotherapy: OPTIMUM trial [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)